Delivery Order SPE2DB20D2104-SPE2DB22FR82F
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,180.34 Firm Fixed Price Delivery Order covers the supply of 4557077483 units of the drug Januvia 100 mg tablets. The contract has an ultimate completion date of May 3, 2022 and was awarded on May 2, 2022. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,969.39 firm fixed-price delivery order is for the supply of 4,567,118,095 units of the drug Januvia 100 mg tablets. The contract has a completion date of February 3, 2025 and was awarded on January 31, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,369.46 firm fixed price delivery order is for the supply of 4,568,824,360 units of the medication Januvia 100 mg tablets. The contract has an ultimate completion date of July 18, 2025 and was competitively awarded with no set-aside designation. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery...
- This federal contract award, valued at $1,091.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award, valued at $6,948.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,181,466 units of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 27, 2023 and is a firm fixed-price delivery order. This award is not associated with a set-aside program and is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,091.46 firm fixed-price delivery order is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held...
- This federal contract award, SPE2DX15D2205|SPE2DX24F72UP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,589.08 firm fixed-price delivery order covers the supply of 4,562,417,448 units of the medication Januvia 100 mg tablets. The contract has an ultimate completion date of October 10, 2023 and was awarded on October 6, 2022. This award is associated with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,938.42 firm fixed-price delivery order covers the supply of Januvia 100 mg tablets to support military healthcare programs. The contract has an ultimate completion date of January 4, 2022 and was awarded on January 3, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,613.23 firm-fixed-price delivery order is for the supply of 4,566,295,825 units of the medication JANUVIA 100 MG TABLET 90S. The award was made on October 31, 2024, with a completion date of November 1, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $84,983.69 fixed-price delivery order contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR82FDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,417.69 firm fixed-price delivery order covers the supply of 4,556,264,930 units of the medication Januvia 100 mg tablets. The contract has a completion date of February 15, 2022 and was awarded on February 14, 2022. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, which runs through November 2026, serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.4k | 2/14/22 |